Shandong Weigao Group Medical Polymer
(OTC) SHWGY
Shandong Weigao Group Medical Polymer Financials at a Glance
Market Cap
$2.56B
Revenue (TTM)
$26.06B
Net Income (TTM)
$3.88B
EPS (TTM)
$0.24
P/E Ratio
9.44
Dividend
$0.12
Beta (Volatility)
0.05 (Low)
Dividend
$0.12
Beta (Volatility)
0.05 (Low)
Price
$2.26
Volume
1,180
Open
$2.26
Price
$2.26
Volume
1,180
Open
$2.26
Previous Close
$2.26
Daily Range
$2.26 - $2.26
52-Week Range
$2.26 - $3.51
Dividend
$0.12
Beta (Volatility)
0.05 (Low)
Price
$2.26
Volume
1,180
Open
$2.26
Previous Close
$2.26
Daily Range
$2.26 - $2.26
52-Week Range
$2.26 - $3.51
SHWGY News
SHWGY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Shandong Weigao Group Medical Polymer
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
12,719
CEO
Rinan Cong, MBA
Website
www.weigaogroup.comHeadquarters
Weihai, 264210, CN
SHWGY Financials
Key Financial Metrics (TTM)
Gross Margin
49%
Operating Margin
17%
Net Income Margin
15%
Return on Equity
8%
Return on Capital
7%
Return on Assets
5%
Earnings Yield
10.59%
Dividend Yield
0.05%
Payout Ratio
44.25%
Stock Overview
Market Cap
$2.56B
Shares Outstanding
1.13B
Volume
1.18K
Short Interest
0.00%
Avg. Volume
549.098
Financials (TTM)
Gross Profit
$6.58B
Operating Income
$2.39B
EBITDA
$3.78B
Operating Cash Flow
$2.79B
Capital Expenditure
$647.43M
Free Cash Flow
$2.14B
Cash & ST Invst.
$8.32B
Total Debt
$4.19B
Shandong Weigao Group Medical Polymer Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$6.64B
-3.7%
Gross Profit
$3.30B
-6.8%
Gross Margin
49.72%
N/A
Market Cap
$2.56B
N/A
Market Cap/Employee
$200.89K
N/A
Employees
12,719
N/A
Net Income
$1.01B
-15.8%
EBITDA
$1.64B
-12.3%
Quarterly Fundamentals
Net Cash
$4.14B
+52.6%
Accounts Receivable
$6.73B
-1.3%
Inventory
$2.28B
-1.1%
Long Term Debt
$4.62B
+34.5%
Short Term Debt
$895.22M
-1.7%
Return on Assets
5.44%
N/A
Return on Invested Capital
7.15%
N/A
Free Cash Flow
$881.57M
-21.1%
Operating Cash Flow
$881.57M
-21.1%